Back to results
US 2017/0254810 A1Published application
Process for detecting prostate cancer biomarkers
OwnerErica Mcjimpsey, Ivinventor
Life of this patent
Estimating the term…
Abstract
A process for detecting prostate cancer biomarkers includes: subjecting seminal plasma fluid to western blot analysis; identifying a first prostate specific antigen (PSA) subform in the seminal plasma fluid, based on the western blot analysis; identifying a second PSA subform in the seminal plasma fluid, based on the western blot analysis; and quantifying a first amount of the first PSA subform and a second amount of the second PSA subform in the seminal plasma fluid to detect prostate cancer biomarkers in a subject from which the seminal plasma fluid was provided.
Claims12
A process for detecting prostate cancer biomarkers, the process comprising:
- subjecting seminal plasma fluid to western blot analysis;
- identifying a first prostate specific antigen (PSA) subform in the seminal plasma fluid, based on the western blot analysis;
- identifying a second PSA subform in the seminal plasma fluid, based on the western blot analysis;
- and
- quantifying a first amount of the first PSA subform and a second amount of the second PSA subform in the seminal plasma fluid to detect prostate cancer biomarkers in a subject from which the seminal plasma fluid was provided.
2 more elements
Dependencies are inferred from the claim text.